Net profit of Rossari Biotech rose 17.77% to Rs 34.13 crore in the quarter ended March 2024 as against Rs 28.98 crore during the previous quarter ended March 2023. Sales rose 16.30% to Rs 472.72 crore in the quarter ended March 2024 as against Rs 406.47 crore during the previous quarter ended March 2023.For the full year,net profit rose 21.84% to Rs 130.69 crore in the year ended March 2024 as against Rs 107.26 crore during the previous year ended March 2023. Sales rose 10.55% to Rs 1830.56 crore in the year ended March 2024 as against Rs 1655.88 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales472.72406.47 16 1830.561655.88 11 OPM %13.4513.43 -13.6413.47 - PBDT61.6453.25 16 238.01207.15 15 PBT45.5737.23 22 177.62144.22 23 NP34.1328.98 18 130.69107.26 22 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 29 April 2024.Powered by Capital Market - Live News

The Board of Rossari Biotech at its meeting held on 06 April 2024 has approved the incorporation of a wholly owned subsidiary in Dubai, United Arab Emirates in Dubai Multi Commodities Centre (DMCC) with an estimate aggregate Capital outlay of over AED 0.40 million in tranches (approximately Rs. 9.08 Million).Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 33.92% to Rs 34.39 crore in the quarter ended December 2023 as against Rs 25.68 crore during the previous quarter ended December 2022. Sales rose 19.14% to Rs 463.77 crore in the quarter ended December 2023 as against Rs 389.27 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales463.77389.27 19 OPM %13.7313.92 - PBDT62.8750.63 24 PBT47.7834.67 38 NP34.3925.68 34 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 20 January 2024.Powered by Capital Market - Live News